ARCHIVES

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

This article is from The Cancer Letter archive.

Vol. 12 No. 29 | July 18, 1986

Download PDF Visit The Full Archive

Related Articles

ASCB Annual Awards, Honors.

January 7, 2000

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Clinical Trials Approved By NCI In November

December 28, 2001

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013